A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 45/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2391416
Leukotriene (LTB4) antagonists enhance the effectiveness of 2',2'- difluoronucleoside anti-cancer agents.
Selon l'invention, des antagonistes de leucotriène (LTB¿4?) augmentent l'efficacité des agents anti-cancéreux 2',2'-difluoronucléosides.
Beight Douglas Wade
Benjamin Roger Stuart
Fleisch Jerome Herbert
Mcmillen William Thomas
Sawyer Jason Scott
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Oncolytic combinations for the treatment of cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oncolytic combinations for the treatment of cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncolytic combinations for the treatment of cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1597430